
Pharmacy UGM – Friday (14/2), the Faculty of Pharmacy UGM received a visit from PT. Mersifarma Tirmaku Mercusana to discuss the potential initiation of a collaboration to strengthen the relationship between academia and the pharmaceutical industry. The meeting, held in the Dean’s Meeting Room (RSP) on the 7th floor of the APSLC Building at the Faculty of Pharmacy UGM, was attended by the Dean of the Faculty of Pharmacy UGM, along with the leadership team and academic staff.
During the meeting, both parties discussed various potential collaborations, including programs to meet the needs of the pharmaceutical workforce. PT. Mersifarma Tirmaku Mercusana, a leading pharmaceutical company, also expressed its interest in supporting pharmaceutical education by providing access to the latest technology and pharmaceutical industry knowledge.
The Dean of the Faculty of Pharmacy UGM, Prof. Dr. apt. Satibi, M.Si., warmly welcomed this collaboration initiative, emphasizing the importance of cooperation between the academic and industrial worlds for advancing research, education, and the development of pharmaceutical products in Indonesia. “This collaboration is expected to make a significant contribution by opening opportunities for our students and graduates to better understand the dynamics of the pharmaceutical industry,” he said.
Both the Faculty of Pharmacy UGM and PT. Mersifarma Tirmaku Mercusana hopes that this collaboration will benefit both parties and, more broadly, contribute to the development of the pharmaceutical industry. The collaboration discussed in this meeting also aligns with the Sustainable Development Goals (SDGs), particularly SDG 3 (Health and Well-Being), SDG 4 (Quality Education), SDG 9 (Industry, Innovation, and Infrastructure), and SDG 17 (Partnerships for the Goals). With this partnership, it is hoped that a synergy will be created to support the achievement of sustainable development and progress in the national health and pharmaceutical industry sectors. (Rara/HumasFA)